ArticleCancers2023

Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments.

Paul V Viscuse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.